Dynavax drops Tdap vaccine after considering phase 1 data, competition

Dynavax drops Tdap vaccine after considering phase 1 data, competition

Source: 
Fierce Biotech
snippet: 

Dynavax is giving up work on its combination vaccine for tetanus, diphtheria and acellular pertussis (Tdap) after mulling phase 1 data for the shot.